Insights On Pharmaceutical Inspection

  1. Building A High-Fidelity Manual Baseline For Tomorrow's Automated Inspection 7/14/2025

    Future-proof your pharma manufacturing. Discover why manual visual inspection remains foundational and how advanced software can build a high-fidelity baseline for automation success.

  2. Enhance Accuracy And Efficiency In Lightweight Applications 2/11/2025

    Streamline your operations within a single framework with advanced checkweighers that enhance industrial quality control with precise weight measurements and regulatory compliance.

  3. Understanding Injectable Drug Container Closure Systems 6/20/2024

    Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

  4. What Is The Biggest Problem With Inspector Training And Qualification? 8/25/2025

    Discover how a truly blind system eliminates bias from the human inspection process, improving data accuracy and validation of automated inspection systems.

  5. HVLD Technology Pre-Filled Syringe Inspection 1/5/2026

    Advanced HVLD technology delivers non-invasive, deterministic inspection for pre-filled syringes. Learn how this method improves reliability and patient safety compared to traditional approaches.

  6. Establishing A Container Closure System 5/13/2026

    As a trusted partner to both established and emerging drug developers, we support the safe, effective containment and delivery of life-saving and life-enhancing medicines.

  7. Physical Contamination Detection 3/23/2026

    Learn how physical contaminants enter production lines and how detection systems like metal detection and X-ray inspection help prevent defects and recalls to strengthen quality control.

  8. Protecting Your Drug Product 5/13/2026

    With patient lives depending on every dose, even minor vulnerabilities in containment or delivery systems can have serious consequences for product integrity and patient outcomes.

  9. Part II: Defining The Dye Ingress Operating Window 2/12/2026

    Learn about the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.

  10. Lessons From FDA 483s And Warning Letters: Cleanroom Compliance 12/8/2025

    Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.